Nancy Magsino, MD
Obstetrics & Gynecology · Katy, TXNPI 1568645828
Payments from drug & device makers
Across 132 payments — averaging $19.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$328
- Exeltis, USA Inc.$222
- Astellas Pharma US Inc$198
- Sumitomo Pharma America, Inc.$194
- Mayne Pharma Commercial LLC$188
- Pfizer$181
- plus $1K from 33 others
What the payments were for
- Food & beverage$2,53996%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $328 |
| Exeltis, USA Inc. | 11 | $222 |
| Astellas Pharma US Inc | 7 | $198 |
| Sumitomo Pharma America, Inc. | 9 | $194 |
| Mayne Pharma Commercial LLC | 9 | $188 |
| Pfizer | 9 | $181 |
| Shield Therapeutics Inc | 9 | $151 |
| Hologic Sales And Service, LLC | 8 | $148 |
| Sage Therapeutics, LLC | 5 | $109 |
| Aurinia Pharma U.S., Inc. | 1 | $86 |
| Therapeuticsmd, Inc. | 3 | $55 |
| Myovant Sciences Inc. | 3 | $54 |
| Evofem Biosciences, Inc. | 3 | $53 |
| Exact Sciences | 3 | $51 |
| Merck | 2 | $45 |
| Johnson & Johnson | 2 | $41 |
| BD | 2 | $38 |
| Minerva Surgical, Inc | 3 | $37 |
| Dexcom, Inc. | 2 | $33 |
| Aspira Women's Health Inc | 2 | $33 |
| Coopersurgical, Inc. | 2 | $30 |
| Vertical Pharmaceuticals, LLC | 2 | $30 |
| Mylan Pharmaceuticals Inc. | 2 | $26 |
| Ascend Therapeutics US, LLC | 2 | $25 |
| Smith+Nephew | 1 | $25 |
| Optumhealth Care Solutions, LLC | 1 | $24 |
| Covidien LP | 1 | $24 |
| Lupin Inc. | 1 | $24 |
| Baxter Healthcare | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Scynexis, Inc. | 1 | $20 |
| Cepheid | 1 | $19 |
| Renovia Inc | 1 | $17 |
| Dilon Technologies, Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Convatec Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $13 |
| Cumberland Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,639 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paroxetine Hcl | 11 | $19 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Katy
- Kelly McCullaghKaty$307K
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
- Cynthia RobbinsFort Worth$7.8M
- John Paul RobertsPlano$4.9M
- Stephen StamatisWeatherford$4.5M
- Parke HedgesSan Antonio$4.2M
- Mary MartinBeaumont$2.8M
- Mark JacobsHouston$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.